299 related articles for article (PubMed ID: 34011540)
1. Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.
Barbosa JAF; Sparapani S; Boulais J; Lodge R; Cohen ÉA
J Virol; 2021 Jul; 95(15):e0097120. PubMed ID: 34011540
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Vpx-Mediated SAMHD1 and Vpr-Mediated Host Helicase Transcription Factor Degradation by Selective Disruption of Viral CRL4 (DCAF1) E3 Ubiquitin Ligase Assembly.
Wang H; Guo H; Su J; Rui Y; Zheng W; Gao W; Zhang W; Li Z; Liu G; Markham RB; Wei W; Yu XF
J Virol; 2017 May; 91(9):. PubMed ID: 28202763
[TBL] [Abstract][Full Text] [Related]
3. Evidence for Vpr-dependent HIV-1 replication in human CD4+ CEM.NKR T-cells.
Zhou T; Dang Y; Baker JJ; Zhou J; Zheng YH
Retrovirology; 2012 Nov; 9():93. PubMed ID: 23134572
[TBL] [Abstract][Full Text] [Related]
4. Studies on the Contribution of Human Cytomegalovirus UL21a and UL97 to Viral Growth and Inactivation of the Anaphase-Promoting Complex/Cyclosome (APC/C) E3 Ubiquitin Ligase Reveal a Unique Cellular Mechanism for Downmodulation of the APC/C Subunits APC1, APC4, and APC5.
Clark AE; Spector DH
J Virol; 2015 Jul; 89(13):6928-39. PubMed ID: 25903336
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 Vpr Protein Enhances Proteasomal Degradation of MCM10 DNA Replication Factor through the Cul4-DDB1[VprBP] E3 Ubiquitin Ligase to Induce G2/M Cell Cycle Arrest.
Romani B; Shaykh Baygloo N; Aghasadeghi MR; Allahbakhshi E
J Biol Chem; 2015 Jul; 290(28):17380-9. PubMed ID: 26032416
[TBL] [Abstract][Full Text] [Related]
6. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
Wang J; Shackelford JM; Selliah N; Shivers DK; O'Neill E; Garcia JV; Muthumani K; Weiner D; Yu XF; Gabuzda D; Finkel TH
DNA Cell Biol; 2008 May; 27(5):267-77. PubMed ID: 18462066
[TBL] [Abstract][Full Text] [Related]
7. Promiscuous Targeting of Cellular Proteins by Vpr Drives Systems-Level Proteomic Remodeling in HIV-1 Infection.
Greenwood EJD; Williamson JC; Sienkiewicz A; Naamati A; Matheson NJ; Lehner PJ
Cell Rep; 2019 Apr; 27(5):1579-1596.e7. PubMed ID: 31042482
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Vpr activates host CRL4-DCAF1 E3 ligase to degrade histone deacetylase SIRT7.
Zhou X; Monnie C; DeLucia M; Ahn J
Virol J; 2021 Mar; 18(1):48. PubMed ID: 33648539
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Vpr hijacks EDD-DYRK2-DDB1
Hossain D; Ferreira Barbosa JA; Cohen ÉA; Tsang WY
J Biol Chem; 2018 Jun; 293(24):9448-9460. PubMed ID: 29724823
[TBL] [Abstract][Full Text] [Related]
10. Dual regulation of L-selectin (CD62L) by HIV-1: Enhanced expression by Vpr in contrast with cell-surface down-modulation by Nef and Vpu.
Giuliani E; Vassena L; Galardi S; Michienzi A; Desimio MG; Doria M
Virology; 2018 Oct; 523():121-128. PubMed ID: 30119013
[TBL] [Abstract][Full Text] [Related]
11. Depletion of anaphase-promoting complex or cyclosome (APC/C) subunit homolog APC1 or CDC27 of Trypanosoma brucei arrests the procyclic form in metaphase but the bloodstream form in anaphase.
Kumar P; Wang CC
J Biol Chem; 2005 Sep; 280(36):31783-91. PubMed ID: 15994309
[TBL] [Abstract][Full Text] [Related]
12. Vpr counteracts the restriction of LAPTM5 to promote HIV-1 infection in macrophages.
Zhao L; Wang S; Xu M; He Y; Zhang X; Xiong Y; Sun H; Ding H; Geng W; Shang H; Liang G
Nat Commun; 2021 Jun; 12(1):3691. PubMed ID: 34140527
[TBL] [Abstract][Full Text] [Related]
13. TPR subunits of the anaphase-promoting complex mediate binding to the activator protein CDH1.
Vodermaier HC; Gieffers C; Maurer-Stroh S; Eisenhaber F; Peters JM
Curr Biol; 2003 Sep; 13(17):1459-68. PubMed ID: 12956947
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 Accessory Protein Vpr Interacts with REAF/RPRD2 To Mitigate Its Antiviral Activity.
Gibbons JM; Marno KM; Pike R; Lee WJ; Jones CE; Ogunkolade BW; Pardieu C; Bryan A; Fu RM; Warnes G; Rowley PA; Sloan RD; McKnight Á
J Virol; 2020 Jan; 94(4):. PubMed ID: 31776272
[TBL] [Abstract][Full Text] [Related]
15. Virion-Associated Vpr Alleviates a Postintegration Block to HIV-1 Infection of Dendritic Cells.
Miller CM; Akiyama H; Agosto LM; Emery A; Ettinger CR; Swanstrom RI; Henderson AJ; Gummuluru S
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424288
[TBL] [Abstract][Full Text] [Related]
16. Defining the interactions and role of DCAF1/VPRBP in the DDB1-cullin4A E3 ubiquitin ligase complex engaged by HIV-1 Vpr to induce a G2 cell cycle arrest.
Gérard FC; Yang R; Romani B; Poisson A; Belzile JP; Rougeau N; Cohen ÉA
PLoS One; 2014; 9(2):e89195. PubMed ID: 24558487
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Vpr-mediated G2 arrest involves the DDB1-CUL4AVPRBP E3 ubiquitin ligase.
Belzile JP; Duisit G; Rougeau N; Mercier J; Finzi A; Cohen EA
PLoS Pathog; 2007 Jul; 3(7):e85. PubMed ID: 17630831
[TBL] [Abstract][Full Text] [Related]
18. WD40 domain of Apc1 is critical for the coactivator-induced allosteric transition that stimulates APC/C catalytic activity.
Li Q; Chang L; Aibara S; Yang J; Zhang Z; Barford D
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10547-52. PubMed ID: 27601667
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 Vpr counteracts HLTF-mediated restriction of HIV-1 infection in T cells.
Yan J; Shun MC; Zhang Y; Hao C; Skowronski J
Proc Natl Acad Sci U S A; 2019 May; 116(19):9568-9577. PubMed ID: 31019079
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Vpr Reprograms CLR4
Yan J; Shun MC; Hao C; Zhang Y; Qian J; Hrecka K; DeLucia M; Monnie C; Ahn J; Skowronski J
mBio; 2018 Oct; 9(5):. PubMed ID: 30352932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
